Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 769-780 of 1,136
Drug study icon
SuspendedNCT03674671

Ketamine Versus Electroconvulsive Therapy in Depression

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Canada
Depression, BipolarityDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT00718510

L-arginine in Treatment as Usual in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00475137

Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for Bipolar II Depression

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

In Canada
Bipolarity, DepressionBehavioralFrom 17 Years to 70 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT01828931

Lifestyle Intervention for Diabetes and Weight Management in Psychosis

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In Canada
Schizophrenia, Depression, ...BehavioralFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia, Depression, ...
Behavioral study icon
Active Not RecruitingNCT00590265

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

This study is looking at whether Northern Light Technology (SADelite lamp) bright light-therapy can help people with Bipolar Type II Disorder or Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Canada
Bipolarity, DepressionBehavioralFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01863459

Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

In Canada
ADHD, Anxiety, ...DrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada
Condition
ADHD, Anxiety, ...
Drug study icon
TerminatedNCT03397446

Lisdexamfetamine for Adults With Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
Eating disordersDrugFrom 18 Years to 55 Years
Countries
Canada
Sponsor
Aaron Keshen
Condition
Eating disorders
Drug study icon
WithdrawnNCT01416220

Lithium Versus Paroxetine in Major Depression

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In Canada
DepressionDrugOver 18 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Depression
Drug study icon
TerminatedNCT00400088

Lithium Versus Paroxetine in people with Major Depression Who Have a Family History of Bipolarity or Suicide

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Canada
Depression, BipolarityDrugOver 18 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT02168127

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

This study exists to understand how the medication PRC-063 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication PRC-063 can improve attention, thinking, or day-to-day functioning.

In Canada
ADHDDrugOver 12 Years
Countries
United States, Canada
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.